PharmaShots | Incisive News in 3 Shots

Subscribe Now

VOLTAIRE-X

Boehringer Ingelheim Reports Results of Cyltezo (biosimilar- adalimumab) in P-III VOLTAIRE-X Study for Moderate-to-Severe Chronic Plaque Psoriasis

Boehringer Ingelheim Reports Results of Cyltezo (biosimilar- adalimumab) in P-III VOLTAIRE-X Study for Moderate-to-Severe Chronic...

April 23, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us